Overexpression of B7-H3 in CD133+ colorectal cancer cells is associated with cancer progression and survival in human patients

Journal of Surgical Research

Volumn 188, Issue 2, 2014, Pages 396-403

  Bin, Zhou ^a,b   Guangbo, Zhang ^b   Yan, Ge ^a   Huan, Zhou ^a   Desheng, Lv ^a   Xueguang, Zhang ^a,b  

^a SOOCHOW UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

B7 H3; CD133; Clinicopathology; Colorectal cancer

Indexed keywords

CD133 ANTIGEN; TUMOR MARKER;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; CELL POPULATION; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TISSUE MICROARRAY; TUMOR GROWTH; TUMOR INVASION;

B7-H3; CD133; CLINICOPATHOLOGY; COLORECTAL CANCER;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; B7 ANTIGENS; COLON; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; GLYCOPROTEINS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PEPTIDES; RECTUM;

EID: 84898809143     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2014.01.014     Document Type: Article

References (39)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics CA Cancer J Clin 55 2005 74
2. A.H. Yin, S. Miraglia, and E.D. Zanjani et al. AC133, a novel marker for human hematopoietic stem and progenitor cells Blood 90 1997 5002
3. D. Corbeil, K. Roper, A. Weigmann, and W.B. Huttner AC133 hematopoietic stem cell antigen: human homologue of mouse kidney prominin or distinct member of a novel protein family? Blood 91 1998 2625
4. S.V. Shmelkov, L. Jun, and R. St Clair et al. Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133 Blood 103 2004 2055
5. G. Ferrandina, M. Petrillo, G. Bonanno, and G. Scambia Targeting CD133 antigen in cancer Expert Opin Ther Targets 13 2009 823
6. Y. Wu, and P.Y. Wu CD133 as a marker for cancer stem cells: progresses and concerns Stem Cells Dev 18 2009 1127
7. L. Ricci-Vitiani, D.G. Lombardi, and E. Pilozzi et al. Identification and expansion of human colon-cancer-initiating cells Nature 445 2007 111
8. D. Horst, L. Kriegl, J. Engel, T. Kirchner, and A. Jung CD133 expression is an independent prognostic marker for low survival in colorectal cancer Br J Cancer 99 2008 1285
9. V. Catalano, S. Di Franco, F. Iovino, F. Dieli, G. Stassi, and M. Todaro CD133 as a target for colon cancer Expert Opin Ther Targets 16 2012 259
10. K. Ieta, F. Tanaka, and N. Haraguchi Biological and genetic characteristics of tumor-initiating cells in colon cancer Ann Surg Oncol 15 2007 638
11. H.N. Lee, S.H. Park, E.K. Lee, R. Bernardo, and C.W. Kim Proteomic profiling of tumor-initiating cells in HT-29 human colorectal cancer cells Biochem Biophys Res Commun 427 2012 171
12. X. Zang, R.H. Thompson, and H.A. Al-Ahmadie et al. B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome Proc Natl Acad Sci U S A 104 2007 19458
13. P.L. Crispen, Y. Sheinin, and T.J. Roth et al. Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma Clin Cancer Res 14 2008 5150
14. J. Sun, L.J. Chen, and G.B. Zhang et al. Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma Cancer Immunol Immunother 59 2010 1163
15. V.A. Ingebrigtsen, K. Boye, C. Tekle, J.M. Nesland, K. Flatmark, and O. Fodstad B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer Int J Cancer 131 2012 2528
16. S. Seaman, J. Stevens, M.Y. Yang, D. Logsdon, and C. Graff-Cherry Genes that distinguish physiological and pathological angiogenesis Cancer Cell 11 2007 539
17. D. Lemke, P.N. Pfenning, and F. Sahm et al. Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasiveness Clin Cancer Res 18 2011 105
18. G. Zhang, H. Zhou, and Y.J. Chen et al. Characterization and application of two novel monoclonal antibodies against 2IgB7-H3: expression analysis of 2IgB7-H3 on dendritic cells and tumor cells Tissue Antigens 66 2005 83
19. C. Coco, G.F. Zannoni, and E. Caredda et al. Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients J Exp Clin Cancer Res 31 2012 71
20. T. Reya, S.J. Morrison, M.F. Clarke, and I.L. Weissman Stem cells, cancer, and cancer stem cells Nature 414 2001 105
21. S.V. Shmelkov, J.M. Butler, and A.T. Hooper et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors J Clin Invest 118 2008 2111
22. C. Chao, J.R. Carmical, and K.L. Ives et al. CD133+ colon cancer cells are more interactive with the tumor microenvironment than CD133- cells Lab Invest 92 2012 420
23. M. Kojima, G. Ishii, and N. Atsumi et al. Immunohistochemical detection of CD133 expression in colorectal cancer: a clinicopathological study Cancer Sci 99 2008 1578
24. H. Xi, and P. Zhao Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma J Clin Pathol 64 2011 498
25. Co-expression of CXCR4 and CD133 proteins is associated with poor prognosis in stage II-III colon cancer patients Exp Ther Med 3 2012 973
26. A. Bellizzi, S. Sebastian, and P. Ceglia et al. Co-expression of CD133 (+)/CD44 (+) in human colon cancer and liver metastasis J Cell Physiol 228 2013 408
27. R. Al Dhaybi, H. Sartelet, J. Powell, and V. Kokta Expression of CD133+ cancer stem cells in childhood malignant melanoma and its correlation with metastasis Mod Pathol 23 2010
28. A.I. Chapoval, J. Ni, and J.S. Lau et al. B7-H3: a costimulatory molecule for T cell activation and IFN-γ production Nat Immunol 2 2001 269
29. Y. Sun, Y. Wang, and J. Zhao et al. B7-H3 and B7-H4 expression in non-small-cell lung cancer Lung Cancer 53 2006 143
30. C. Wu, J. Jiang, and M. Tan et al. Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis World J Gastroenterol 12 2006 457
31. S.A. Boorjian, Y. Sheinin, and P.L. Crispen et al. T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival Clin Cancer Res 14 2008 4800
32. B.D. Lehmann, M.S. Paine, and A.M. Brooks et al. Senescence-associated exosome release from human prostate cancer cells Cancer Res 68 2008 7864
33. Z. Zhou, N. Luther, and G.M. Ibrahim et al. B7-H3, a potential therapeutic target, is expressed in diffuse intrinsic pontine glioma J Neurooncol 111 2013 257
34. Y. Nagai, H. Aso, and H. Ogasawara et al. Anterior pituitary progenitor cells express costimulatory molecule 4Ig-B7-H3 J Immunol 181 2008 6073
35. V. Ling, P.W. Wu, and V. Spaulding et al. Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss Genomics 82 2003 365
36. J. Leitner, C. Klauser, and W.F. Pickl et al. B7-H3 is a potent inhibitor of human T-cell activation: no evidence for B7-H3 and TREML2 interaction Eur J Immunol 39 2009 1754
37. C. Roberta, D. Alessandra, and A. Raffaella et al. Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis Proc Natl Acad Sci U S A 101 2004 12640
38. L. Luo, A.I. Chapoval, and D.B. Flies et al. B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells J Immunol 173 2004 5445
39. J. Sun, F. Fu, and W. Gu et al. Origination of new immunological functions in the costimulatory molecule B7-H3: the role of exon duplication in evolution of the immune system PLoS One 6 2011 e24751